Persons qualified to prescribe or supply medicinal products must have access to a neutral, objective source of information about products available on the market. Whereas it is nevertheless for the Member States to take all measures necessary to this end, in the light of their own particular situation.
Recital 52, Directive (EU) 2001/83
Judgment of the Court (Fourth Chamber) of 22 April 2010. The Queen, on the application of Association of the British Pharmaceutical IndustryDecision
Recitals 2, 47, 50 and 52 in the preamble to Directive 2001/83 are worded as follows: The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. … The …
22 Apr 2010 · 62009CJ0062
Judgment of the Court (Third Chamber) of 5 May 2011. Novo Nordisk AS v Ravimiamet.Decision
Recitals 47, 48 and 52 in the preamble to Directive 2001/83 state as follows: The advertising of medicinal products to persons qualified to prescribe or supply them contributes to the information available to such persons. Nevertheless, …
5 May 2011 · 62009CJ0249
Opinion of Mr Advocate General Jääskinen delivered on 19 October 2010. Novo Nordisk AS v Ravimiamet.Decision
Recitals 47, 48 and 52 of Directive 2001/83 concern the advertising of medicinal products to professionals. They provide as follows: The advertising of medicinal products to persons qualified to prescribe or supply them contributes to the …
19 Oct 2010 · 62009CC0249